Dexcom (DXCM) Cash from Operations (2010 - 2026)

Dexcom (DXCM) has reported Cash from Operations for 17 consecutive years, with $269.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations fell 11.16% year-over-year to $269.2 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 77.05% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 45.6% from the prior year.
• Cash from Operations was $269.2 million for Q2 2026 at Dexcom, down from $525.6 million in the prior quarter.
• Over five years, Cash from Operations peaked at $659.9 million in Q3 2025 and troughed at $71.0 million in Q1 2022.
• A 5-year average of $257.9 million and a median of $239.2 million in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations declined 25.89% in 2024 and soared 230.78% in 2025, its largest moves.
• Over 5 years, Cash from Operations stood at $132.5 million in 2022, then climbed by 0.83% to $133.6 million in 2023, then jumped by 125.6% to $301.4 million in 2024, then retreated by 2.46% to $294.0 million in 2025, then fell by 8.44% to $269.2 million in 2026.
• The last three Cash from Operations figures came in at $269.2 million (Q2 2026), $525.6 million (Q1 2026), and $294.0 million (Q4 2025), per Business Quant data.